# Capricor Therapeutics, Inc. (CAPR): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Capricor Therapeutics, Inc. (CAPR) is 6/100, ranked against 24,000+ stocks in 35 markets (Quality 21, Value 32, Momentum 23, each scored against its sector).

- StockRank: 6/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 21, Value 32, Momentum 23: each a 0-100 percentile within Healthcare.
- Position: #24,747 overall, #2,429 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 5.74 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors sold USD 2.3M.

Source: https://moatmap.ai/stock/CAPR
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker